Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1999-11-02
2000-11-07
Carlson, Karen Cochrane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 530402, 536 231, 536 234, 435 691, A61K 3800, C07K 100, C07H 2104, C12P 2106
Patent
active
061437204
ABSTRACT:
The present invention is directed to polynucleotides and polypeptides for a novel member of the lipocalin family. The expression of this novel polynucleotide is restricted to testis and mammary gland, particularly breast tumor tissue. The polypeptide has been designated zlipo1. The present invention also includes antibodies to the zlipo1 polypeptides.
REFERENCES:
LIFESEQ.TM. Clone Information Results (INC1730294), Incyte Pharmaceuticals, Inc., 1996.
LIFESEQ.TM. Clone Information Results (INC1213903), Incyte Pharmaceuticals, Inc., 1996.
LIFESEQ.TM. Clone Information Results (INC1214269), Incyte Pharmaceuticals, Inc., 1996.
LIFESEQ.TM. Clone Information Results (INC1731309), Incyte Pharmaceuticals, Inc., 1996.
LIFESEQ.TM. Clone Information Results (INC3673491), Incyte Pharmaceuticals, Inc., 1997.
Hillier et al., WashU-Merck EST Project, Genbank Acc. No. AA460323, 1997.
Hillier et al., WashU-Merck EST Project, Genbank Acc. No. AA460385, 1997.
Strausberg, Cancer Genome Anatomy, Project, Genbank Acc. No. AA936288, 1997.
Strausberg, Cancer Genome Anatomy Project, Genbank Acc. No. AA977608, 1997.
Carlson Karen Cochrane
Sawislak Deborah A.
Srivastava Devesh
ZymoGenetics Inc.
LandOfFree
Lipocalin homologs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipocalin homologs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipocalin homologs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1641130